4d
GlobalData on MSNEli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASHLilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli Lilly ...
EXCLUSIVE: Premiere Entertainment Group has licensed North American rights to Vertical for the family comedy F+, starring six ...
Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...
3d
PlanetF1.com on MSNF1 drivers and their partners: Who are the grid currently dating or married to?F1 drivers spend a lot of time travelling the world, and some of them do so with friends, family or loved ones.
3d
GlobalData on MSNAbcuro secures $200m as it eyes approval for rare muscle disease drugThe funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...
5d
GlobalData on MSNSuper Bowl ad for copycat weight loss drugs stokes pharma power debateControversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...
Maybe I'm an arrogant Luddite, but I still think I can write a better column about Indiana than artificial intelligence can.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results